Evidence supporting the use of: Vitamin E (tocopheryl acetate)
For the health condition: Hepatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (tocopheryl acetate) has been studied for its potential role in supporting liver health, particularly in patients with certain types of hepatitis, most notably non-alcoholic steatohepatitis (NASH), a form of chronic hepatitis. The rationale for its use is based on its antioxidant properties, as oxidative stress is thought to contribute to liver cell injury in hepatitis. Several clinical trials have evaluated the effects of Vitamin E supplementation in patients with NASH. For example, the PIVENS trial (published in the New England Journal of Medicine, 2010) showed that 800 IU/day of Vitamin E improved histological features of NASH in non-diabetic adults, particularly in reducing liver inflammation and steatosis. However, evidence is less robust or absent for its use in treating viral hepatitis (like hepatitis B or C). Some small studies have explored Vitamin E in chronic viral hepatitis with mixed or inconclusive results, and there is no established recommendation for its use in these populations.

Overall, while Vitamin E has shown benefit in certain types of hepatitis (notably NASH), the evidence is moderate and primarily limited to this subset of liver disease. Major liver and hepatology guidelines suggest considering Vitamin E for non-diabetic adults with biopsy-proven NASH, but not for other forms of hepatitis. Thus, its use is supported by scientific evidence in a specific context, but not broadly for all hepatitis cases.

More about Vitamin E (tocopheryl acetate)
More about Hepatitis

Products containing Vitamin E (tocopheryl acetate)

We currently have no products on Vitabase that contain this ingredient.